Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Internal Medicine
•
Chronic kidney disease
•
Nephrology
What is your approach to managing patients with suspected osmotic nephrosis from monthly IVIG infusions?
Related Questions
What is your approach to patients with advanced chronic kidney disease who are taking aluminum containing medications?
What are your criteria for starting tolvaptan in adult patients diagnosed with autosomal dominant polycystic kidney disease?
How often do you screen for cerebral aneurysms in patients with autosomal dominant polycystic kidney disease who do not have a family history of intracranial aneurysms or for whom the family history is unknown?
Do you recommend dietary protein restriction in your patients with chronic kidney disease?
What is your approach to weaning dialysis in a patient with AKI on CKD and CHF who now has resolved AKI but a history of recurrent episodes of decompensated heart failure?
What is your approach to patients with chronic kidney disease who are found to have pelviectasis without hydronephrosis on renal ultrasound imaging?
Do you recommend patients with chronic kidney disease avoid supplements containing creatine?
When do you recommend testing for APOL1 variants in patients with proteinuric chronic kidney disease?
Is the phosphorus-lowering benefit of patiromer compelling enough to switch a patient with chronic hyperkalemia and hyperphosphatemia from sodium zirconium cyclosilicate to patiromer?
Are there instances when you prefer serum creatinine over cystatin C when estimating GFR in a patient with CKD?
